Notícias Sobre o Forex

Fed Leaves Interest Rates Unchanged But Forecasts Higher Rates For Longer

Fed Leaves Interest Rates Unchanged But Forecasts Higher Rates For Longer

In a widely anticipated move, the Federal Reserve announced on Wednesday that it has decided to leave interest rates unchanged. The Fed said it decided to maintain the target range for the federal funds rate at 5.25 to 5.50 percent after raising rates by 25 basis points in July.
RTTNews | 685 dias atrás
Swiss Market Ends Notably Higher

Swiss Market Ends Notably Higher

The Switzerland market ended notably higher on Wednesday, with investors picking up stocks, shrugging off a government report that said the nation's economy will expand significantly below average in both 2023 and 2024.
RTTNews | 685 dias atrás
more news
Euro Advances Amid Risk Appetite

Euro Advances Amid Risk Appetite

The euro was higher against its major counterparts in the European session on Wednesday amid risk appetite, as investors awaited the Fed's summary of economic projections and the updated quarterly rate projections — known as the dot plot —at the conclusion of a two-day policy meeting later in the day.
RTTNews | 685 dias atrás
Eli Lilly Sues Clinics Over Unauthorized Mounjaro Drug Sale

Eli Lilly Sues Clinics Over Unauthorized Mounjaro Drug Sale

Eli Lilly has filed lawsuits against several medical spas, wellness centers and compounding pharmacies for unauthorized sale of diabetes drug Mounjaro (tirzepatide). These clinics allegedly use the drug for weight loss treatment. Mounjaro, approved for type 2 diabetes, is only available from and manufactured by Lilly. They are commercially available in a pre-filled single-dose pen only.
RTTNews | 685 dias atrás
Merck Says FDA Grants Priority Review For KEYTRUDA+Concurrent Chemoradiotherapy For Cervical Cancer

Merck Says FDA Grants Priority Review For KEYTRUDA+Concurrent Chemoradiotherapy For Cervical Cancer

Merck & Co Inc. (MRK), known as MSD outside of the U.S. and Canada, announced Wednesday the U.S. Food and Drug Administration (FDA) has accepted for priority review a new supplemental Biologics License Application (sBLA) seeking approval for KEYTRUDA, Merck's anti-PD-1 therapy, in combination with external beam radiotherapy (EBRT) plus concurrent chemotherapy, followed by brachytherapy (concurrent chemoradiotherapy) as treatment with definitive intent for newly diagnosed patients with high-risk locally advanced cervical cancer.
RTTNews | 685 dias atrás
UK Inflation Softens In August

UK Inflation Softens In August

UK consumer price inflation unexpectedly slowed to an 18-month low in August, official data showed ahead of the Bank of England's monetary policy announcement on Thursday, raising chances of a pause in the interest rate hike cycle. The consumer price index posted an annual increase of 6.7 percent in August after rising 6.8 percent in July, the Office for National Statistics reported Wednesday.
RTTNews | 685 dias atrás

Stay up to date!

Add Notícias to your browser

Extension Picture